NO20012985L - Anvendelse av apomorfin i fremstilling av et medikament for behandling av organisk erektil dysfunksjon i hanner - Google Patents

Anvendelse av apomorfin i fremstilling av et medikament for behandling av organisk erektil dysfunksjon i hanner

Info

Publication number
NO20012985L
NO20012985L NO20012985A NO20012985A NO20012985L NO 20012985 L NO20012985 L NO 20012985L NO 20012985 A NO20012985 A NO 20012985A NO 20012985 A NO20012985 A NO 20012985A NO 20012985 L NO20012985 L NO 20012985L
Authority
NO
Norway
Prior art keywords
apomorphine
males
drug
manufacture
treatment
Prior art date
Application number
NO20012985A
Other languages
English (en)
Norwegian (no)
Other versions
NO20012985D0 (no
Inventor
Karen Kling
Renee J Perdok
Dustin D Ruff
Original Assignee
Abbott Lab
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Abbott Lab filed Critical Abbott Lab
Publication of NO20012985D0 publication Critical patent/NO20012985D0/no
Publication of NO20012985L publication Critical patent/NO20012985L/no

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/47—Quinolines; Isoquinolines
    • A61K31/485—Morphinan derivatives, e.g. morphine, codeine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A61P15/10—Drugs for genital or sexual disorders; Contraceptives for impotence
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0053—Mouth and digestive tract, i.e. intraoral and peroral administration
    • A61K9/006—Oral mucosa, e.g. mucoadhesive forms, sublingual droplets; Buccal patches or films; Buccal sprays

Landscapes

  • Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Epidemiology (AREA)
  • Emergency Medicine (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Endocrinology (AREA)
  • Reproductive Health (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Gynecology & Obstetrics (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Other In-Based Heterocyclic Compounds (AREA)
NO20012985A 1998-12-17 2001-06-15 Anvendelse av apomorfin i fremstilling av et medikament for behandling av organisk erektil dysfunksjon i hanner NO20012985L (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US09/213,567 US6291471B1 (en) 1998-12-17 1998-12-17 Use of apomorphine for the treatment of organic erectile dysfunction in males
PCT/US1999/029449 WO2000035457A1 (en) 1998-12-17 1999-12-13 Use of apomorphine in the manufacture of a medicament for the treatment of organic erectile dysfunction in males

Publications (2)

Publication Number Publication Date
NO20012985D0 NO20012985D0 (no) 2001-06-15
NO20012985L true NO20012985L (no) 2001-08-16

Family

ID=22795606

Family Applications (1)

Application Number Title Priority Date Filing Date
NO20012985A NO20012985L (no) 1998-12-17 2001-06-15 Anvendelse av apomorfin i fremstilling av et medikament for behandling av organisk erektil dysfunksjon i hanner

Country Status (22)

Country Link
US (1) US6291471B1 (pl)
EP (1) EP1140094A1 (pl)
JP (1) JP2003521462A (pl)
KR (1) KR20010101241A (pl)
CN (1) CN1335772A (pl)
AR (1) AR021912A1 (pl)
AU (1) AU2175800A (pl)
BG (1) BG105664A (pl)
BR (1) BR9916114A (pl)
CA (1) CA2354601A1 (pl)
CZ (1) CZ20012084A3 (pl)
HK (1) HK1043303A1 (pl)
HU (1) HUP0201618A3 (pl)
IL (1) IL143410A0 (pl)
NO (1) NO20012985L (pl)
NZ (1) NZ511790A (pl)
PL (1) PL354920A1 (pl)
SK (1) SK8262001A3 (pl)
TR (1) TR200101719T2 (pl)
TW (1) TW577740B (pl)
WO (1) WO2000035457A1 (pl)
ZA (1) ZA200104146B (pl)

Families Citing this family (21)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6566368B2 (en) * 1994-04-22 2003-05-20 Pentech Pharmaceuticals, Inc. Apomorphine-containing dosage form for ameliorating male erectile dysfunction
BR0005797A (pt) * 2000-03-20 2001-10-16 Abbott Lab Métodos para o tratamento de disfunção sexual com apomorfina em nìveis de concentração plasmática especificados
WO2002041894A2 (en) * 2000-11-22 2002-05-30 Abbott Laboratories Selective dopamine d4 receptor agonists for treating sexual dysfunction
AR032556A1 (es) * 2001-02-08 2003-11-12 Pharmacia Corp Medicamento de accion inmediata para el tratamiento de la disfuncion sexual
JP2005526790A (ja) * 2002-03-19 2005-09-08 ミシェル ホリック アポモルフィンおよび類縁体の配糖体およびオルトエステル配糖体誘導体、ならびにそれらの使用方法
SE0202365D0 (sv) 2002-08-05 2002-08-05 Pharmacia Ab New formulation and use thereof
US20040204439A1 (en) * 2003-04-14 2004-10-14 Staniforth John Nicholas Composition, device, and method for treating sexual dysfunction via inhalation
CA2522231A1 (en) * 2003-04-14 2004-10-21 Vectura Ltd Pharmaceutical compositions comprising apomorphine for pulmonary inhalation
US7648995B2 (en) * 2004-04-13 2010-01-19 The Mclean Hospital Corporation R(—)-11-hydroxyaporphine derivatives and uses thereof
GB2437488A (en) * 2006-04-25 2007-10-31 Optinose As Pharmaceutical oily formulation for nasal or buccal administration
US8431591B2 (en) * 2007-07-12 2013-04-30 The Mclean Hospital Corporation R(−)-2-methoxy-11-hydroxyaporphine and derivatives thereof
BRPI0800596A2 (pt) 2008-01-31 2009-09-22 Univ Minas Gerais método para a potencialização da função erétil através do uso das composições farmacêuticas de toxina tx2-6 da aranha phoneutria nigriventer
PT2651357T (pt) 2010-12-16 2020-06-17 Sunovion Pharmaceuticals Inc Películas sublinguais
KR101374500B1 (ko) * 2012-10-09 2014-03-13 울산대학교 산학협력단 Ｒ(-)-프로필노르아포모르핀을 유효성분으로 포함하는 암의 예방 또는 치료용 약학 조성물
PT2981271T (pt) 2013-04-05 2019-02-19 Boehringer Ingelheim Int Utilizações terapêuticas de empagliflozina
US20140303097A1 (en) 2013-04-05 2014-10-09 Boehringer Ingelheim International Gmbh Pharmaceutical composition, methods for treating and uses thereof
US11813275B2 (en) 2013-04-05 2023-11-14 Boehringer Ingelheim International Gmbh Pharmaceutical composition, methods for treating and uses thereof
CA2909728C (en) 2013-04-18 2022-12-06 Boehringer Ingelheim International Gmbh Therapeutic uses of empagliflozin
WO2016174155A1 (en) * 2015-04-30 2016-11-03 Boehringer Ingelheim International Gmbh Methods and pharmaceutical compositions comprising a sglt2 inhibitor for treating or improving erectile dysfunction
WO2017168174A1 (en) 2016-04-02 2017-10-05 N4 Pharma Uk Limited New pharmaceutical forms of sildenafil
WO2019241585A1 (en) * 2018-06-14 2019-12-19 Astrazeneca Uk Limited Methods for treating erectile dysfunction with a cgmp-specific phosphodiesterase 5 inhibitor pharmaceutical composition

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5256652A (en) 1987-11-12 1993-10-26 Pharmedic Co. Topical compositions and methods for treatment of male impotence
US5270323A (en) 1990-05-31 1993-12-14 Pfizer Inc. Method of treating impotence
US5292520A (en) 1990-09-13 1994-03-08 Akzo N.V. Stabilized solid pharmaceutical composition containing acid addition salts of a basic drug and an alkaline stabilizer
DK0689438T3 (da) 1993-03-26 2003-09-29 Franciscus Wilhelmus He Merkus Farmaceutiske præparater til intranasal administration af apomorfin
DK0978282T3 (da) * 1994-04-22 2006-04-10 Pentech Pharmaceuticals Inc Sublingualt præparat indeholdende apomorphin til diagnosticering af funktionel impotens
US5562917A (en) 1994-12-23 1996-10-08 Pentech Pharmaceuticals, Inc. Transdermal administration of apomorphine
US5624677A (en) * 1995-06-13 1997-04-29 Pentech Pharmaceuticals, Inc. Controlled release of drugs delivered by sublingual or buccal administration
US5888534A (en) 1995-06-13 1999-03-30 Pentech Pharmaceuticals, Inc. Controlled release of drugs delivered by sublingual or buccal administration
US5688499A (en) 1996-03-13 1997-11-18 Queen's University At Kingston Antagonism of endothelin actions
DE19652268C2 (de) 1996-12-16 2000-06-29 Lohmann Therapie Syst Lts Arzneizubereitung für die Freisetzung von Apomorphin in der Mundhöhle

Also Published As

Publication number Publication date
TR200101719T2 (tr) 2002-08-21
EP1140094A1 (en) 2001-10-10
NZ511790A (en) 2004-04-30
SK8262001A3 (en) 2002-01-07
BG105664A (en) 2002-02-28
WO2000035457A1 (en) 2000-06-22
BR9916114A (pt) 2003-01-14
HUP0201618A2 (en) 2002-09-28
CZ20012084A3 (cs) 2002-01-16
JP2003521462A (ja) 2003-07-15
TW577740B (en) 2004-03-01
AR021912A1 (es) 2002-09-04
PL354920A1 (pl) 2004-03-22
CN1335772A (zh) 2002-02-13
HUP0201618A3 (en) 2003-03-28
ZA200104146B (en) 2002-08-21
CA2354601A1 (en) 2000-06-22
HK1043303A1 (zh) 2002-09-13
IL143410A0 (en) 2002-04-21
AU2175800A (en) 2000-07-03
KR20010101241A (ko) 2001-11-14
US6291471B1 (en) 2001-09-18
NO20012985D0 (no) 2001-06-15

Similar Documents

Publication Publication Date Title
NO20012985L (no) Anvendelse av apomorfin i fremstilling av et medikament for behandling av organisk erektil dysfunksjon i hanner
IS2494B (is) Notkun á morfólínóli til meðhöndlunar á kynferðislegri vanvirkni
FI972205A0 (fi) cGmp-PDE:n estäjiä erektiohäiriön hoidossa
NO20003845L (no) Behandling av kvinnelig seksuell dysfunksjon
NO20021963D0 (no) Anvendelse av organiske forbindelser av sykdom
NO20022979D0 (no) Anvendelse av organiske forbindelser
CY2006007I2 (el) Χρηση αναστολεων cgmp-φωσφοδιεστερασης στην αγωγη της ανικανοτητας
NO20014379D0 (no) Anvendelse av Xenon for behandling av Neurointoksikasjoner
AR027945A1 (es) Uso de pramipexol en el tratamiento de transtornos de adiccion
DK1702618T3 (da) Brug af ET743 i kombinationsterapi med dexamethason til behandling af cancer
NO995823D0 (no) Terapeutisk middel for ereksjonsdysfunksjon
NO20021301D0 (no) Anvendelse av CSAIDS ved rinovirusinfeksjon
NO20013645D0 (no) Anvendelse av pyridazino[4,5-b]indol-1-acetamid-derivater for fremstilling av medisiner for behandling av sykdommer relatert tildysfunksjonen av perifere benzodiazepinreseptorer
ID29790A (id) PENGGUNAAN IMIDAZO(1,5-a)-PIRIDO(3,2-e)-PIRAZINON SEBAGAI OBAT
NO20024442L (no) Behandling av seksuell dysfunksjon med apomorfin
EE200200511A (et) Hüdroksüfenüülpiperasinüülmetüülbensamiidi derivaadid valu raviks
NO20030978D0 (no) Behandling av diuresedysfunksjon
ATE261434T1 (de) Triptolid-derivate geeignet zur behandlung von autoimmunkrankheiten
NO20013596D0 (no) Slambehandling
DE50009813D1 (de) Kombinationpräparat zur behandlung von sexueller dysfunktion
NO20001894L (no) Anvendelse av TNF-antagonister som medikamenter for behandling av septiske sykdommer
NO20022101D0 (no) Peptider for behandling av erektil dysfunksjon
IT1312060B1 (it) Uso dell'acido alfa lipoico nel trattamento antimetastatico.
NO20030762L (no) Forbedret spesifisitet i behandling av sykdommer
FI20002612A0 (fi) Yhdistelmäterapia serotoniinivälityksen häiriöiden hoitamiseksi

Legal Events

Date Code Title Description
FC2A Withdrawal, rejection or dismissal of laid open patent application